Antenatal HCV Screening in Egypt: Paving the Pa...

By Thanusha Pillay

July 24, 2024

Introduction to Hepatitis C in Egypt Globally, 58 million people live with chronic hepatitis C virus (HCV) infection. Although no vaccine exists, affordable, safe, and highly effective short-co...
Health Economic Assessment of Nirsevimab for Respiratory Syncytial Virus in H...
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
Cost-Effectiveness of Skin Cancer Prevention Strategies
Game-Changer in Atopic Dermatitis Care: Abrocitinib’s Cost-Effectivenes...
Transformation of Health Technology Assessment in Türkiye
Fremanezumab: Cost-Effective Relief for Chronic Migraine
Enhancing Global Health through Cost-Effectiveness Analysis
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Economic Benefits of Preventive Health Programs